Taevas
South KoreaFood & Dietary Supplements
Product Registration
Market Access for Product-Registration in South Korea
Navigating the complexities of global market access is paramount for successful product registration. Taevas Life Sciences provides comprehensive strategies to ensure your life sciences products achieve optimal market entry and sustained commercial viabil
Market
Global
Industry
Product-Registration
Regulator
Global Health Authorities & Payer Bodies
Timeline
4-6 weeks (initial strategy development)
Deliverables
Comprehensive Strategy Report, Market Access Roadmap, Payer Value Dossier
What We Deliver
6 Pillars of Market Access for Global Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory & Payer Landscape Analysis
Thorough analysis of regulatory requirements, health technology assessment (HTA) processes, and reimbursement policies across target global markets. We identify key decision-makers and potential barriers to entry.
In-depth country-specific market intelligence
Identification of HTA and reimbursement drivers
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1
Discovery & Scope Definition
We begin with an in-depth consultation to understand your product, target markets, and existing regulatory status. This phase defines the scope and objectives of our market access strategy.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Increasing Regulatory Divergence
The global regulatory landscape is becoming increasingly fragmented, requiring sophisticated strategies to navigate diverse national requirements and accelerate multi-country product registration without compromising market access potential.
Payer Scrutiny and Value Demands
Global payers are demanding greater evidence of clinical superiority and economic value. Successful product registration now necessitates a proactive and integrated market access approach from early development stages to ensure reimbursement.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A detailed document outlining market entry strategies, HTA considerations, and reimbursement pathways for target global markets.
Payer Value Dossier (Global Core)
A comprehensive compilation of clinical and economic evidence tailored to articulate your product's value to international payers.
Pricing & Reimbursement Roadmap
A strategic plan detailing optimal pricing corridors, negotiation tactics, and reimbursement submission timelines for key regions.
Regulatory-Market Access Integration Plan
A blueprint aligning regulatory submission strategies with market access requirements to streamline global product registration.
Who This Is For
Use Cases
Orphan Drug
Expediting Orphan Drug Access in Multiple Regions
A biotech company sought to register a novel orphan drug across the EU, US, and Japan. Taevas developed a synchronized regulatory and market access strategy, leveraging expedited pathways and tailored value propositions for each region.
Outcome
Achieved concurrent registration and favorable reimbursement decisions in all target markets, significantly reducing time to patient access.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your global product registration challenges into market access triumphs. Our expert team is ready to guide your product's journey to global success.
Accelerate Time to Market
Maximize Commercial Potential
Navigate Complex Regulations
Secure Favorable Reimbursement